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Abstract
Objectives—Through recent genome-wide association studies (GWAS), several groups have
reported significant association between variants in the alpha 1C subunit of the L-type voltage-
gated calcium channel (CACNA1C) and bipolar disorder (BP) in European and European-
American cohorts. We performed a family-based association study to determine whether
CACNA1C is associated with BP in the Latino population.
Methods—This study consisted of 913 individuals from 215 Latino pedigrees recruited from the
United States, Mexico, Guatemala, and Costa Rica. The Illumina GoldenGate Genotyping Assay
was used to genotype 58 single-nucleotide polymorphisms (SNPs) that spanned a 602.9 kb region
encompassing the CACNA1C gene including two SNPs (rs7297582 and rs1006737) previously
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shown to associate with BP. Individual SNP and haplotype association analyses were performed
using Family-Based Association Test (version 2.0.3) and Haploview (version 4.2) software.
Results—An eight-locus haplotype block that included these two markers showed significant
association with BP (global marker permuted p = 0.0018) in the Latino population. For individual
SNPs, this sample had insufficient power (10%) to detect associations with SNPs with minor
effect (odds ratio = 1.15).
Conclusions—Although we were not able to replicate findings of association between
individual CACNA1C SNPs rs7297582 and rs1006737 and BP, we were able to replicate the
GWAS signal reported for CACNA1C through a haplotype analysis that encompassed these
previously reported significant SNPs. These results provide additional evidence that CACNA1C is
associated with BP and provides the first evidence that variations in this gene might play a role in
the pathogenesis of this disorder in the Latino population.
Keywords
bipolar disorder; calcium channels; genetic association studies; haplotypes; Hispanic Americans;
L-type; pedigree; polymorphism; single nucleotide
Bipolar disorder (BP) is an often chronic and debilitating mental disorder affecting
approximately 1–4% of the population (1, 2). Family, twin, and adoption studies on BP have
shown that there is a substantial genetic component (3, 4), as BP has one of the highest
heritability rates of all known psychiatric disorders (1). Over the past several years, genome-
wide association studies (GWAS) have produced several successes in identifying genetic
variants that contribute to genetically complex human disorders (5–16). Recently, a few
research groups have performed independent GWAS of BP (11, 17–22), with little overlap
amongst the single-nucleotide polymorphisms (SNPs) most strongly associated with BP
(23). However, a meta-analysis of three GWAS of BP identified a SNP within the calcium
channel, voltage-dependent, L-type, alpha 1C subunit (CACNA1C) gene, rs1006737, as
being strongly associated with the risk of BP (21). A subsequent meta-analysis combining
data from GWAS of BP and major depressive disorder (MDD) reported two SNPs in a 10.5-
kb region within the CACNA1C gene which exceeded a genome-wide significance level
(rs1006737 and rs7297582) (20).
There has been increasing evidence in recent years that alterations in calcium signaling are
involved in the pathophysiology of BP (32). The CACNA1C gene located on chromosome
12p13.3 encodes the major constituent of the brain L-type voltage-gated calcium channels
that are critical to dendritic calcium influx in response to synaptic activity (33, 34). Reports
have associated SNPs in CACNA1C with an increase in grey matter density in the amygdala
and hypothalamus (35), total grey matter (36), and brainstem volume (37). Neuroimaging
studies of healthy individuals report that the rs1006737 risk allele modulates brain function
during tasks of reward and emotional processing (38, 39), verbal fluency (40), attention
networks (41), and episodic and prefrontal cortex (PFC) working memory (38, 42). The
CACNA1C rs1006737 polymorphism also impacts ventrolateral PFC activation during fear
processing in BP carriers of the risk allele but not their unaffected relatives (43). In addition,
studies have shown that carriers of the rs1006737 variant show a pronounced effect on
measures of psychosocial functioning, including significantly higher scores on tests for
depression, anxiety, interpersonal sensitivity, obsessive-compulsive thoughts, and
neuroticism, even in the absence of disease (44). These studies suggest that calcium channel
dysfunction may contribute in part to the genetic etiology of BP through alterations in the
functional activity of brain circuitries.
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Although there is mounting evidence that CACNA1C is involved in the genetic etiology of
BP, the genetic studies performed to date have been almost exclusively centered on
populations with European ancestry. The replication of significant GWAS findings in
diverse populations is needed in order to corroborate initial findings from European studies
and characterize their genetic contribution to BP in other ethnicities. In order to address this
issue, we have designed a family-based association study to try and validate the GWAS-
significant CACNA1C SNPs in a large set of families with Latin American (Latino)
ancestry.
Materials and methods
Study samples
The sample consisted of 215 Latino pedigrees in which BP probands and extended family
members were recruited from the United States (Texas, New Mexico, California), Mexico
(Mexico City, Monterrey), Costa Rica, and Guatemala. Inclusion criteria required a proband
with a bipolar disorder type I (BP-I) diagnosis with at least one sibling with a clinical
diagnosis of BP-I or schizoaffective BP (SABP), and a minimum of two additional first-
degree relatives willing to participate. Extended pedigrees were collected when possible to
include other family members with a history of affective or psychotic disorders. The sample
consisted of 157 case-parent trios and 258 affected subjects with one parent genotyped. All
subjects reported ancestry from Mexico or Central America. Family structure based on
number of affected family members and country of origin is listed in Table 1. Previous
genetic structure analysis has shown that these populations are closely related, with high
levels of admixture consisting of three major ancestral populations (Caucasian, Native
American, and African) (45).
Subjects signed Institutional Review Board (IRB)-approved written informed consent forms
prior to enrolling in the study.
The procedures were approved by the IRB of Texas Tech University Health Science Center
and respective IRBs in each participating site and country, and the study was performed in
accordance with the Helsinki Declaration of 1975.
All study participants were diagnosed using DSM-IV criteria (46), by a best-estimation
consensus procedure using the Diagnostic Interview for Genetic Studies (DIGS) (47),
Family Interview for Genetic Studies (FIGS) (48), and available psychiatric records as
previously described (49). The 215 Hispanic pedigrees under study contained 929
individuals: 466 of whom were diagnosed with BP-I and 16 of whom were diagnosed with
SABP. Of the study participants with a diagnosis of BP-I or SABP, 200 were male and 282
were female.
Genotyping
DNA was isolated from lymphoblastoid cell lines established and stored for each study
participant at the National Institute of Mental Health (NIMH) Center for Collaborative
Genetic Studies. SNP selection covering the CACNA1C gene was based on a tagging SNP
approach (r2 ≥ 0.9) using the SNP browser™ Software version 4.0.1 based on data from the
CEU (Utah residents with ancestry from northern and western Europe) HapMap population
(50). Known CACNA1C variants rs1006737 (20, 21) and rs7297582 (20), which reached
genome-wide significance in previous meta-analysis GWAS studies, were included in the
panel. Additional proximal SNPs to these known variants were chosen from the National
Center for Biotechnology Information (NCBI) dbSNP (51) based on criteria that SNPs were
validated and had heterozygosity > 0.4. A total of 58 SNPs were genotyped using a custom-
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designed Illumina GoldenGate SNP assay according to the manufacturer’s protocol
(Illumina, San Diego, CA), blind to subject diagnosis and characteristics.
Genetic markers failing standard quality control criteria were excluded from further
analysis: missing genotype > 0.1, minor allele frequency < 0.01, and exact Hardy–Weinberg
equilibrium p < 0.01. Also excluded from the analysis were individuals with a missing
genotype rate > 0.1, or Mendelian errors > 2. The discrepancy rate on 2% duplicate
genotyping was < 0.002. A total of 57 SNPs for 213 pedigrees (913 individuals) were
retained for further statistical analysis.
Statistical analyses
Analyses of individual SNPs were completed with the Family-Based Association Test
(FBAT) version 2.0.3 (52), which was used for testing association under the null hypothesis
of ‘no association and no linkage’ using an additive genetic model. To thoroughly test the
locus identified by the two individual SNPs previously reported to be in association with BP,
we also identified a haplotype block which included those SNPs and analyzed the
haplotypes for association. Haploview version 4.2 (53) was used to visualize linkage
disequilibrium (LD) relationships between all genotyped variants (57 SNPs) within and
surrounding the CACNA1C region (54) and to construct LD blocks following the D′ method
described by Gabriel et al. (55). Haplotype analyses were performed using the Haplotype-
Based Association Testing (HBAT) assessment in the FBAT program. Haplotype-specific
and global-permuted p-values were calculated for individual haplotype tests conducted
under biallelic mode in haplotype FBAT, assuming an additive genetic model. In order to
maximize power in the statistical analyses, permutation procedures were implemented to
calculate the empirical p-values derived from 10,000 permutations. The significance level
for all statistical tests was two-tailed (p < 0.05).
Power analyses were estimated using the transmission disequilibrium test (TDT) for discrete
traits of the Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/) with α =
0.05 and D′ of 0.9. The current family study design (n = 215) yielded an estimate of 0.65
[odds ratio (OR) = 1.75] and 0.82 (OR = 2.00) for a gene of moderate effect and a power
estimate of 0.40 (OR = 1.5) and 0.10 (OR =1.15) for a gene with minor effect. We
calculated that our sample had reasonable power to detect a common risk variant, but would
be insufficient to detect a susceptibility locus with a minor effect as seen in genetic studies
of the CACNA1C gene for BP. To make optimal use of our data, we performed haplotype-
based tests to increase the power of the association study (55).
Results
The primary aim of this study was to test to see if findings of association of SNPs rs1006737
and rs7297582 in the CACNA1C gene with BP, as reported in a European ancestry cohort
by Liu et al. (20), were valid in other populations, specifically in the Latino population.
When tested individually, we found no significant association between these two SNPs and
BP (rs7297582, Z = 0.306, p = 0.760; rs1006737, Z = 0.725, p = 0.469) in the Latino
population studied.
Given the negative findings of association for SNPs rs1006737 and rs7297582, we wished to
test whether SNPs in LD with these variants would associate with BP in our Latino cohort.
We used a tagged-SNP approach to cover the CACNA1C gene in addition to several SNPs
in close proximity to rs1006737 and rs7297582, assuming that these SNPs were not
functional SNPs but rather variants in LD with true causal mutation. Twelve LD blocks were
identified in our sample (Fig. 1). Haploblock 4 encompasses both rs1006737 and rs7297582
SNPs, previously shown to associate with BP. Allele frequencies and the results of FBAT
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for single SNP analysis for the eight SNPs comprising Haploblock 4 are shown in Table 2.
Univariate (single-marker) FBAT demonstrated no preferential transmission for any of the
variant alleles tested (Table 2).
Since the use of haplotypes may provide greater statistical power in association studies of
common genetic variation than can be obtained with individual SNPs (55), we conducted
haplotype analyses focusing on Haploblock 4 which contained SNPs previously associated
with BP. To determine whether any specific haplotype would confer a higher risk for BP,
the specific and global-haplotype FBAT tests of association were performed. One common
and three rare haplotypes displayed significant association under an additive model (Table
3). The p-values of the whole haplotype permutation test were also statistically significant
(χ2 sum, p = 0.0018) (Table 3). Of note, among these four disease-associated haplotypes,
three (GGGCGGGA, GGGCGAGA, and AAAGAGGA) showed protective effect with
negative Z-scores and one showed a susceptibility effect with a positive Z-score
(GAAGGAAG). Interestingly, the specific alleles previously shown to be associated with
BP on SNPs rs1006737 (A) and rs7297582 (A), were also seen on the GAAGGAAG
haplotype showing increased risk (Z = 2.236, p = 0.031). The common haplotype
significantly associated with BP was present across all countries in our cohort, while the
other three haplotypes were very rare.
Discussion
In the present study, we attempted to validate, in nearly 1,000 Latinos, the significant
CACNA1C variants associated with BP identified in populations of predominantly
European ancestry (11, 18, 20, 21). When analyzed individually, we were unable to replicate
association of SNPs rs7297582 and rs1006737 with BP in the Latino population. However,
these two previously identified SNPs have not been shown to be functionally significant
within the CACNA1C gene and may only be in LD with functional variants at this locus.
Moreover, allele frequencies of genotyped markers in strong LD with the two previously
associated SNPs are highly variable across ancestral populations (hapmap.ncbi.nlm.nih.gov),
suggesting the likelihood of a differential profile of CACNA1C variants with ethnicity
(Table 4). Given the negative findings of our single locus tests compared to previous
associations found in the Caucasian population, combined with the finding that haplotypes at
this locus are associated with BP in the Latino population, the possibility remains that there
might be additional functional variants in both the European and Latino ancestry populations
that might still be in strong LD with rs7297582 and rs1006737.
It is known that in the presence of multiple tightly linked markers a haplotype test may be
more powerful to detect association than corresponding single-locus tests (56). Haplotype-
based analysis of the haploblock encompassing the two previously reported SNPs associated
with BP provided significant evidence for association with BP in the Latino population. Our
complementary LD block-based analysis revealed that an eight-locus haploblock (consisting
of rs769087, rs1006737, rs2159100, rs4765905, rs2370413, rs7297582, rs758170, and
rs1860002) provided stronger evidence of association than single-marker analysis. In
affected individuals, three distinct haplotypes (GGGCGGGA, GGGCGAGA, and
AAAGAGGA) were under-represented and one haplotype (GAAGGAAG) was over-
represented, giving rise to a significant permutated whole marker haplotypic association (χ2
sum, p = 0.0018). We performed a conditional analysis to see if the association was driven
by the two previously reported risk variants. We removed the two variants and performed
the family-based haplotype association test with the remaining six variants under identical
parameters outlined in the methods section. These results were very similar to our initial
findings, in which one common and three rare haplotypes were significantly associated (see
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Supplementary Table 1). The whole marker permutation test was also significant, indicating
that the association is not driven by these two previously reported SNPs.
Since the fruition of this study, The Psychiatric GWAS Consortium (PGC) BP Working
Group published their results of the most comprehensive GWAS of BP to date, including
16,731 samples and a replication sample of 46,918 individuals. They report a genome-wide
significant SNP, rs4765913, in CACNA1C associated with BP (57). A combined analysis of
PGC BP and PGC schizophrenia showed stronger association of this SNP compared to the
BP GWAS alone (26, 57). The PGC significant variant falls between two haploblocks
identified in our Latino population (Fig. 2). This SNP is approximately 6 kb downstream
from the proximal marker of the associated haploblock and approximately 16 kb upstream of
the next closest marker. Although we did not test SNP rs4765913 directly, we believe it is
very likely, due to its proximity, to be in strong LD with the haploblock associated with BP
in our Latino cohort, thus providing additional support for our findings.
Another recently published study reported a significant association of rs4765905 located
within CACNA1C with BP and schizophrenic patients (n = 16,373) compared to control
subjects (n = 14,044) (27). SNP rs4765905 was also genotyped in our current study and is
nested in the LD block used in this association study. Taken as a whole, these results
provide compelling evidence that this region of the CACNA1C gene plays a role in the
pathogenesis of BP.
There are several limitations of the present study. First, compared to the previous studies in
European ancestry populations, this was a smaller sample size. Larger sample sizes might be
required in order to detect statistically significant association for single, common alleles in
the Latino population. Secondly, this study only utilized published SNPs and did not use a
sequencing approach to detect other potential SNPs or genetic variants within the gene
which might be more directly causal for the disease. Finally, the combination of families
from several countries may introduce heterogeneity into the analysis. However, if that were
to be the case, this would diminish the chances of identifying association of gene variants.
There are also some strengths to the present study: family-based association analyses were
used, which prevent potential false positive results due to stratification in case-control
analyses, and a narrow phenotype of carefully diagnosed BP-I and SABP cases were utilized
as the affected phenotype of interest, drawn from families with multiplex BP cases.
In conclusion, these results provide the first evidence that genetic variations in CACNA1C
might play a role in the pathogenesis of BP in the Latino population. We provide further
support to previous case-control studies in Caucasian populations, strengthening the notion
that genetic variation of CACNA1C influences the susceptibility to BP. Further
investigations of the CACNA1C gene are thus warranted to increase our understanding of its
role in the pathogenesis of BP. Careful replication with appropriate designs in independent
sample sets from the Latino population is needed as advocated for stringent confirmation of
genetic associations. Furthermore, comprehensive fine-mapping and resequencing will be
required to characterize the disease gene architecture of this region in the Latino population.
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Fig. 1.
Calcium channel, voltage-dependent, L-type, alpha 1C subunit (CACNA1C) haplotype
blocks in the Latino population. Linkage disequilibrium plot of the CACNA1C gene (shown
as a black line) and adjacent regions with respect to the 57 single-nucleotide polymorphisms
(SNPs) with minor allele frequency > 10%. The data visualized here using Haploview V4.2
(53) are based on the current genotyping data from the Latino population. Squares indicate
pair-wise r2 values on a red-scale with D′ = 1 (red) through to D′ = 0 (white). Linkage
disequilibrium blocks, as defined in Haploview, are represented by the triangular lines.
Order of Blocks and SNPs (SNPs within Blocks in bold) from left to right: Block 1 (14 kb):
rs765125, rs2299657, rs2283269; rs2238013; rs2238019; Block 2 (18 kb): rs2283281,
rs758723, rs2299660, rs2299661, rs2239131; rs2238034; rs2238042; rs2239014;
rs2238044; rs758171; Block 3 (16 kb): rs2239024, rs2238056; Block 4 (69 kb): rs769087,
rs1006737, rs2159100, rs4765905, rs2370413, rs7297582, rs758170, rs1860002; Block 5
(20 kb): rs2239047, rs2283301, rs2238070; rs740418; Block 6 (31 kb): rs2238078,
rs2283304, rs2283306, rs2239062, rs2238084; rs2239063; rs1009281; Block 7 (1 kb):
rs2239066, rs2239068, rs2239071; rs2239074; rs2239087; Block 8 (7 kb): rs1860094,
rs887001; rs1541452; rs4765951; Block 9 (14 kb): rs2239117, rs4765959; rs2370600;
rs929492; Block 10 (7 kb): rs2238090, rs11832738; rs215976; Block 11 (16 kb):
rs2283326, rs215993; rs758561; Block 12 (7 kb): rs1420725, rs740727.
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Fig. 2.
Calcium channel, voltage-dependent, L-type, alpha 1C subunit (CACNA1C) haploblocks in
the Latino population in relation to single-nucleotide polymorphisms (SNPs) previously
associated with bipolar disorder. Haploview V4.2 (53) was used to define linkage
disequilibrium (LD) blocks represented by the triangular lines, based on the current
genotyping data from the Latino population. The 111.5 kb CACNA1C gene region (shown
as a black line) is depicted with respect to 11 genotyped SNPs forming the two haploblocks.
Block 1 consists of 8 SNPs in strong LD including rs1006737a and rs7297582c, SNPs that
have previously shown to associate with bipolar disorder (20, 21). Ripke et al. (27) reported
rs4765905b associated with bipolar disorder and schizophrenia. Subsequent to this study,
Sklar et al. (57) reported a bipolar disorder associated SNP (rs4765913d), which is
positioned between Blocks 1 and 2. Squares indicate pair-wise r2 values on a red-scale with
D′ = 1 (red) through to D′ = 0 (white).
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